Authors | Giuseppe Visani, Pietro Maria Stefani, Saveria Capria, Lara Malerba, Piero Galieni, Francesco Gaudio, Giorgina Specchia, Giovanna Meloni, Filippo Gherlinzoni, Roberta Gonella, Marco Gobbi, Armando Santoro, Felicetto Ferrara, Marco Rocchi, Enrique M Ocio, Maria Dolores Caballero, Federica Loscocco, Alessandro Isidori |
Journal | Blood
(Blood)
Vol. 124
Issue 19
Pg. 3029-31
(Nov 06 2014)
ISSN: 1528-0020 [Electronic] United States |
PMID | 25377565
(Publication Type: Clinical Trial, Letter, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antimetabolites, Antineoplastic
- Antineoplastic Agents, Alkylating
- Nitrogen Mustard Compounds
- Cytarabine
- Bendamustine Hydrochloride
- Melphalan
|
Topics |
- Antimetabolites, Antineoplastic
(therapeutic use)
- Antineoplastic Agents, Alkylating
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Bendamustine Hydrochloride
- Combined Modality Therapy
- Cytarabine
(therapeutic use)
- Drug Resistance, Neoplasm
- Hematopoietic Stem Cell Transplantation
(methods)
- Humans
- Lymphoma, Non-Hodgkin
(drug therapy)
- Melphalan
(therapeutic use)
- Nitrogen Mustard Compounds
(therapeutic use)
- Transplantation, Autologous
|